Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Lidocaine topical patch effective in treating post-herpetic neuralgia

Aug. 30, 1996

Potential tachykinin NK1 antagonists from Merck & Co.

Aug. 23, 1996

Further nitric oxide synthase inhibitors from Chugai

Aug. 23, 1996

The Wellcome Foundation claims nitric oxide synthase inhibitors

Aug. 23, 1996

Nitric oxide synthase inhibitors from Merck & Co.

Aug. 23, 1996

BASF reveals NMDA and AMPA antagonists

Aug. 23, 1996

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Study of senile plaques guide Alzheimer's development

Aug. 23, 1996

Study indicates that estrogen may delay Alzheimer's disease onset

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...